Summit Rock Advisors, LP Diversified Active

Location: New York, NY

CIK: 0001540951 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 1, 2022

Total Value: $122M (100.0% shares, 0.0% debt)

Holdings (8)

XLE SELECT SECTOR SPDR TR 49.3%

Value $60.3M Shares 843,269 Est. Cost $76.44 Unrealized —

IWN ISHARES TR 46.7%

Value $57.18M Shares 420,000 Est. Cost $157.31 Unrealized —

VT VANGUARD INTL EQUITY INDEX F 2.2%

Value $2.674M Shares 31,329 Est. Cost $101.28 Unrealized —

WMS ADVANCED DRAIN SYS INC DEL 0.5%

Value $671K Shares 7,448 Est. Cost $101.05 Unrealized 0.0%

DAWN DAY ONE BIOPHARMACEUTICALS I 0.5%

Value $593K Shares 33,125 Est. Cost $20.55 Unrealized -49.8%

CLOV CLOVER HEALTH INVESTMENTS CO 0.4%

Value $451K Shares 210,639 Est. Cost $8.56 Unrealized -68.9%

PHAT PHATHOM PHARMACEUTICALS INC 0.2%

Value $288K Shares 34,100 Est. Cost $38.42 Unrealized -73.2%

DYN DYNE THERAPEUTICS INC 0.2%

Value $240K Shares 34,887 Est. Cost $14.05 Unrealized -51.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
XLE	SELECT SECTOR SPDR TR	843,269	$60.3M	49.3%	$76.44	—	ENERGY	81369Y506
IWN	ISHARES TR	420,000	$57.18M	46.7%	$157.31	—	RUS 2000 VAL ETF	464287630
VT	VANGUARD INTL EQUITY INDEX F	31,329	$2.674M	2.2%	$101.28	—	TT WRLD ST ETF	922042742
WMS	ADVANCED DRAIN SYS INC DEL	7,448	$671K	0.5%	$101.05	0.0%	COM	00790R104
DAWN	DAY ONE BIOPHARMACEUTICALS I	33,125	$593K	0.5%	$20.55	-49.8%	COM	23954D109
CLOV	CLOVER HEALTH INVESTMENTS CO	210,639	$451K	0.4%	$8.56	-68.9%	COM CL A	18914F103
PHAT	PHATHOM PHARMACEUTICALS INC	34,100	$288K	0.2%	$38.42	-73.2%	COM	71722W107
DYN	DYNE THERAPEUTICS INC	34,887	$240K	0.2%	$14.05	-51.0%	COM	26818M108